Chemical name:
17β-hydroxyandrost-4-en-3-one heptanoate
Molecular formula:
C₂₆H₄₀O₃
Hormone Replacement Therapy (HRT):
Used to treat male hypogonadism — a condition where the body doesn’t produce enough natural testosterone.
Delayed Puberty in Males:
Prescribed to induce puberty and develop secondary sexual characteristics in adolescent males with delayed onset.
Gender-Affirming Therapy:
Used in transgender men (female-to-male) as part of masculinizing hormone therapy to promote male physical traits such as deeper voice, facial hair, and muscle mass.
Anemia and Muscle-Wasting Disorders:
Sometimes used to help stimulate red blood cell production and preserve lean muscle in chronic illnesses (though this use has become less common with newer medications).
Osteoporosis Treatment (rare):
Occasionally used to improve bone density in men with low testosterone levels contributing to bone loss.
Ingredients:
Medium Chain Triglycerides oil, Benzyl Benzoate, Benzyl Alcohol
Standard Dosage Protocol
Medical Use:
For Male Hypogonadism (Low Testosterone):
Typical dosage: 50–200 mg every 1 to 2 weeks via intramuscular injection (IM).
Some protocols use 100 mg weekly or 200 mg every 2 weeks, depending on blood testosterone levels and patient response.
For Delayed Puberty in Males:
25–50 mg every 2–4 weeks for 4–6 months, carefully adjusted based on physical development.
Bodybuilding / Performance Use (non-medical):
• Beginner cycle: 250–500 mg per week (split into two injections, e.g., Monday and Thursday).
• Intermediate cycle: 500–750 mg per week.
• Advanced cycle: 750–1000 mg per week, sometimes combined with other anabolic compounds (e.g., nandrolone, drostanolone, or boldenone).
